Xenon Pharmaceuticals Inc (XENE)
40.56
-1.88
(-4.43%)
USD |
NASDAQ |
May 10, 16:00
40.56
0.00 (0.00%)
After-Hours: 19:59
Xenon Pharmaceuticals Total Return Level: 42.44 for May 9, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 09, 2024 | 42.44 |
May 08, 2024 | 42.93 |
May 07, 2024 | 43.43 |
May 06, 2024 | 43.19 |
May 03, 2024 | 43.75 |
May 02, 2024 | 43.00 |
May 01, 2024 | 42.49 |
April 30, 2024 | 40.65 |
April 29, 2024 | 42.73 |
April 26, 2024 | 40.50 |
April 25, 2024 | 40.10 |
April 24, 2024 | 39.50 |
April 23, 2024 | 41.09 |
April 22, 2024 | 40.01 |
April 19, 2024 | 39.88 |
April 18, 2024 | 40.31 |
April 17, 2024 | 41.63 |
April 16, 2024 | 41.49 |
April 15, 2024 | 41.31 |
April 12, 2024 | 41.30 |
April 11, 2024 | 42.97 |
April 10, 2024 | 42.43 |
April 09, 2024 | 43.03 |
April 08, 2024 | 42.62 |
April 05, 2024 | 42.25 |
Date | Value |
---|---|
April 04, 2024 | 42.21 |
April 03, 2024 | 41.30 |
April 02, 2024 | 41.47 |
April 01, 2024 | 42.14 |
March 28, 2024 | 43.05 |
March 27, 2024 | 43.00 |
March 26, 2024 | 42.66 |
March 25, 2024 | 42.70 |
March 22, 2024 | 44.00 |
March 21, 2024 | 43.45 |
March 20, 2024 | 43.79 |
March 19, 2024 | 44.35 |
March 18, 2024 | 42.89 |
March 15, 2024 | 43.96 |
March 14, 2024 | 43.67 |
March 13, 2024 | 45.08 |
March 12, 2024 | 44.25 |
March 11, 2024 | 44.37 |
March 08, 2024 | 46.24 |
March 07, 2024 | 46.16 |
March 06, 2024 | 45.96 |
March 05, 2024 | 46.00 |
March 04, 2024 | 45.95 |
March 01, 2024 | 46.84 |
February 29, 2024 | 47.20 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
8.08
Minimum
Mar 18 2020
50.04
Maximum
Feb 09 2024
25.18
Average
26.94
Median
May 11 2022
Total Return Level Benchmarks
Acasti Pharma Inc | 2.76 |
Aurinia Pharmaceuticals Inc | 5.172 |
Edesa Biotech Inc | 4.514 |
Lexaria Bioscience Corp | 3.58 |
ESSA Pharma Inc | 6.27 |